GlassScriptPhysician profile
Juan E Reinoso
NPI 1154311397
$586.89
in general payments reported to CMS, 2019-2025
15 companies · $56.72 in 2025
The $56.72 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.32 · 2021: $186 · 2022: $88.81 · 2023: $23.45 · 2024: $215 · 2025: $56.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235 · Education: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.00 |
| Education | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $108.32 | 2024 | Veozah |
| Minerva Surgical, INC | $92.02 | 2024 | |
| Aspira Women'S Health INC | $78.89 | 2021 | |
| Mayne Pharma Commercial LLC | $52.25 | 2021-2025 | |
| Agile Therapeutics, INC. | $43.71 | 2021 | |
| Applied Medical Resources Corporation | $35.47 | 2022 | |
| Medtronic, INC. | $35.26 | 2025 | Truclear |
| Mylan Pharmaceuticals INC. | $25.67 | 2021 | |
| Myovant Sciences INC. | $23.90 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.45 | 2023 | |
| Abbvie INC. | $21.03 | 2022 | |
| Therapeuticsmd, INC. | $17.32 | 2020 | |
| Avion Pharmaceuticals | $15.11 | 2022 | |
| Coopersurgical, INC. | $14.49 | 2024 | Paragard T 380a |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Reinoso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.